Skip to main content
SpringerLink
Log in

The Management of Thrombotic Lesions in the Cardiac Catheterization Laboratory

  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Plaque rupture with superimposed thrombosis is the major mechanism of acute coronary syndromes. Although angiography underestimates the presence of thrombi, their detection is a poor prognostic indicator which is proportional to their size. Although emergent percutaneous coronary intervention (PCI) in the setting of ST elevation myocardial infarction (STEMI) and early PCI in the setting of unstable angina and non-STEMI were shown to be preferred strategies, the presence of angiographic thrombosis by virtue of causing micro and macro embolization can reduce the benefit of the intervention. Antiplatelet therapy especially using glycoprotein IIb/IIIa inhibitors reduces thrombus size, and improves myocardial perfusion and ventricular function. Routine manual aspiration prior to PCI in STEMI also improves myocardial flow and reduces distal embolization and improves survival. Distal embolic protection devices and mechanical thrombectomy do not have the same clinical benefits however, rheolytic thrombectomy may have a role in large vessels with a large thrombi.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. (1999). Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet, 354(9180), 708–715.

  2. Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R., Frey, M. J., Lakkis, N., et al. (2001). Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. The New England Journal of Medicine, 344(25), 1879–1887.

    Article  PubMed  CAS  Google Scholar 

  3. Wallentin, L., Lagerqvist, B., Husted, S., Kontny, F., Stahle, E., & Swahn, E. (2000). Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during InStability in Coronary artery disease. Lancet, 356(9223), 9–16.

    Article  PubMed  CAS  Google Scholar 

  4. Fox, K. A., Poole-Wilson, P. A., Henderson, R. A., Clayton, T. C., Chamberlain, D. A., Shaw, T. R., et al. (2002). Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet, 360(9335), 743–751.

    Article  PubMed  CAS  Google Scholar 

  5. Mehta, S. R., Granger, C. B., Boden, W. E., Steg, P. G., Bassand, J. P., Faxon, D. P., et al. (2009). Early versus delayed invasive intervention in acute coronary syndromes. The New England Journal of Medicine, 360(21), 2165–2175.

    Article  PubMed  CAS  Google Scholar 

  6. Neumann, F. J., Kastrati, A., Pogatsa-Murray, G., Mehilli, J., Bollwein, H., Bestehorn, H. P., et al. (2003). Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. Journal of the American Medical Association, 290(12), 1593–1599.

    Article  PubMed  CAS  Google Scholar 

  7. DeWood, M. A., Spores, J., Notske, R., Mouser, L. T., Burroughs, R., Golden, M. S., et al. (1980). Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. The New England Journal of Medicine, 303(16), 897–902.

    Article  PubMed  CAS  Google Scholar 

  8. (1993). Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation, 87(1), 38–52.

  9. Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., et al. (2001). Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation, 103(21), 2550–2554.

    PubMed  CAS  Google Scholar 

  10. Gotoh, K., Minamino, T., Katoh, O., Hamano, Y., Fukui, S., Hori, M., et al. (1988). The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks. Circulation, 77(3), 526–534.

    Article  PubMed  CAS  Google Scholar 

  11. Freeman, M. R., Williams, A. E., Chisholm, R. J., & Armstrong, P. W. (1989). Intracoronary thrombus and complex morphology in unstable angina. Relation to timing of angiography and in-hospital cardiac events. Circulation, 80(1), 17–23.

    Article  PubMed  CAS  Google Scholar 

  12. Napodano, M., Ramondo, A., Tarantini, G., Peluso, D., Compagno, S., Fraccaro, C., et al. (2009). Predictors and time-related impact of distal embolization during primary angioplasty. European Heart Journal, 30(3), 305–313.

    Article  PubMed  Google Scholar 

  13. Zhao, X. Q., Theroux, P., Snapinn, S. M., & Sax, F. L. (1999). Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction. Angiographic results from the PRISM-PLUS trial (Platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms). PRISM-PLUS Investigators. Circulation, 100(15), 1609–1615.

    PubMed  CAS  Google Scholar 

  14. Henriques, J. P., Zijlstra, F., Ottervanger, J. P., de Boer, M. J., van 't Hof, A. W., Hoorntje, J. C., et al. (2002). Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. European Heart Journal, 23(14), 1112–1117.

    Article  PubMed  CAS  Google Scholar 

  15. Falk, E., Shah, P. K., & Fuster, V. (1995). Coronary plaque disruption. Circulation, 92(3), 657–671.

    PubMed  CAS  Google Scholar 

  16. Davies, M. J. (1996). Stability and instability: two faces of coronary atherosclerosis. The Paul Dudley White lecture 1995. Circulation, 94(8), 2013–2020.

    PubMed  CAS  Google Scholar 

  17. Davies, M. J. (1997). The composition of coronary-artery plaques. The New England Journal of Medicine, 336(18), 1312–1314.

    Article  PubMed  CAS  Google Scholar 

  18. Davies, M. J., & Thomas, A. (1984). Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. The New England Journal of Medicine, 310(18), 1137–1140.

    Article  PubMed  CAS  Google Scholar 

  19. Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992). The pathogenesis of coronary artery disease and the acute coronary syndromes (2). The New England Journal of Medicine, 326(5), 310–318.

    Article  PubMed  CAS  Google Scholar 

  20. Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992). The pathogenesis of coronary artery disease and the acute coronary syndromes (1). The New England Journal of Medicine, 326(4), 242–250.

    Article  PubMed  CAS  Google Scholar 

  21. Farb, A., Burke, A. P., Tang, A. L., Liang, T. Y., Mannan, P., Smialek, J., et al. (1996). Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation, 93(7), 1354–1363.

    PubMed  CAS  Google Scholar 

  22. Hackett, D., Davies, G., Chierchia, S., & Maseri, A. (1987). Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. The New England Journal of Medicine, 317(17), 1055–1059.

    Article  PubMed  CAS  Google Scholar 

  23. Saraf, S., Christopoulos, C., Salha, I. B., Stott, D. J., & Gorog, D. A. (2010). Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction. J Am Coll Cardiol, 55(19), 2107–2115.

    Article  PubMed  Google Scholar 

  24. Mizuno, K., Satomura, K., Miyamoto, A., Arakawa, K., Shibuya, T., Arai, T., et al. (1992). Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. The New England Journal of Medicine, 326(5), 287–291.

    Article  PubMed  CAS  Google Scholar 

  25. Anderson, H. V., Cannon, C. P., Stone, P. H., Williams, D. O., McCabe, C. H., Knatterud, G. L., et al. (1995). One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. Journal of the American College of Cardiology, 26(7), 1643–1650.

    Article  PubMed  CAS  Google Scholar 

  26. Davies, M. J., Thomas, A. C., Knapman, P. A., & Hangartner, J. R. (1986). Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation, 73(3), 418–427.

    Article  PubMed  CAS  Google Scholar 

  27. Sherman, C. T., Litvack, F., Grundfest, W., Lee, M., Hickey, A., Chaux, A., et al. (1986). Coronary angioscopy in patients with unstable angina pectoris. The New England Journal of Medicine, 315(15), 913–919.

    Article  PubMed  CAS  Google Scholar 

  28. Sianos, G., Papafaklis, M. I., Daemen, J., Vaina, S., van Mieghem, C. A., van Domburg, R. T., et al. (2007). Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. Journal of the American College of Cardiology, 50(7), 573–583.

    Article  PubMed  CAS  Google Scholar 

  29. Holmes, D. R., Jr., Hartzler, G. O., Smith, H. C., & Fuster, V. (1981). Coronary artery thrombosis in patients with unstable angina. British Heart Journal, 45(4), 411–416.

    Article  PubMed  Google Scholar 

  30. Vetrovec, G. W., Cowley, M. J., Overton, H., & Richardson, D. W. (1981). Intracoronary thrombus in syndromes of unstable myocardial ischemia. American Heart Journal, 102(6 Pt 2), 1202–1208.

    Article  PubMed  CAS  Google Scholar 

  31. Zack, P. M., Ischinger, T., Aker, U. T., Dincer, B., & Kennedy, H. L. (1984). The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina pectoris. American Heart Journal, 108(6), 1408–1412.

    Article  PubMed  CAS  Google Scholar 

  32. Lindahl, B., Diderholm, E., Lagerqvist, B., Venge, P., & Wallentin, L. (2001). Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. Journal of the American College of Cardiology, 38(4), 979–986.

    Article  PubMed  CAS  Google Scholar 

  33. White, C. J., Ramee, S. R., Collins, T. J., Escobar, A. E., Karsan, A., Shaw, D., et al. (1996). Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation, 93(2), 253–258.

    PubMed  CAS  Google Scholar 

  34. Singh, M., Berger, P. B., Ting, H. H., Rihal, C. S., Wilson, S. H., Lennon, R. J., et al. (2001). Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). The American Journal of Cardiology, 88(10), 1091–1096.

    Article  PubMed  CAS  Google Scholar 

  35. de Feyter, P. J., de Jaegere, P. P., Murphy, E. S., & Serruys, P. W. (1992). Abrupt coronary artery occlusion during percutaneous transluminal coronary angioplasty. American Heart Journal, 123(6), 1633–1642.

    Article  PubMed  Google Scholar 

  36. de Feyter, P. J., van den Brand, M., Laarman, G. J., van Domburg, R., Serruys, P. W., & Suryapranata, H. (1991). Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management, and follow-up. Circulation, 83(3), 927–936.

    PubMed  Google Scholar 

  37. Napodano, M., Pasquetto, G., Sacca, S., Cernetti, C., Scarabeo, V., Pascotto, P., et al. (2003). Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. Journal of the American College of Cardiology, 42(8), 1395–1402.

    Article  PubMed  Google Scholar 

  38. Antman, E. M. (2001). The search for replacements for unfractionated heparin. Circulation, 103(18), 2310–2314.

    PubMed  CAS  Google Scholar 

  39. Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G., Fromell, G. J., Goodman, S., et al. (1997). A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. The New England Journal of Medicine, 337(7), 447–452.

    Article  PubMed  CAS  Google Scholar 

  40. Antman, E. M., McCabe, C. H., Gurfinkel, E. P., Turpie, A. G., Bernink, P. J., Salein, D., et al. (1999). Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation, 100(15), 1593–1601.

    PubMed  CAS  Google Scholar 

  41. Dumaine, R., Borentain, M., Bertel, O., Bode, C., Gallo, R., White, H. D., et al. (2007). Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials. Archives of Internal Medicine, 167(22), 2423–2430.

    Article  PubMed  CAS  Google Scholar 

  42. Stone, G. W., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., et al. (2006). Bivalirudin for patients with acute coronary syndromes. The New England Journal of Medicine, 355(21), 2203–2216.

    Article  PubMed  CAS  Google Scholar 

  43. Stone, G. W., Witzenbichler, B., Guagliumi, G., Peruga, J. Z., Brodie, B. R., Dudek, D., et al. (2008). Bivalirudin during primary PCI in acute myocardial infarction. The New England Journal of Medicine, 358(21), 2218–2230.

    Article  PubMed  CAS  Google Scholar 

  44. (1997). Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tirofiban for Outcomes and REstenosis. Circulation, 96(5), 1445–1453.

  45. (1997). Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study. Lancet, 349(9063), 1429–1435.

  46. (1997). Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Integrilin to Minimise Platelet Aggregation and Coronary Thrombosis-II. Lancet, 349(9063), 1422–1428.

  47. (1994). Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med, 330(14), 956–961.

  48. Collet, J. P., Montalescot, G., Lesty, C., Mishal, Z., Soria, J., Choussat, R., et al. (2001). Effects of Abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention. Circulation, 103(19), 2328–2331.

    PubMed  CAS  Google Scholar 

  49. Collet, J. P., Montalescot, G., Lesty, C., Soria, J., Mishal, Z., Thomas, D., et al. (2001). Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(1), 142–148.

    Article  PubMed  CAS  Google Scholar 

  50. Collet, J. P., Montalescot, G., Lesty, C., & Weisel, J. W. (2002). A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circulation Research, 90(4), 428–434.

    Article  PubMed  CAS  Google Scholar 

  51. Marciniak, S. J., Jr., Mascelli, M. A., Furman, M. I., Michelson, A. D., Jakubowski, J. A., Jordan, R. E., et al. (2002). An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregates. Thrombosis and Haemostasis, 87(6), 1020–1025.

    PubMed  CAS  Google Scholar 

  52. Moser, M., Bertram, U., Peter, K., Bode, C., & Ruef, J. (2003). Abciximab, eptifibatide, and tirofiban exhibit dose-dependent potencies to dissolve platelet aggregates. Journal of Cardiovascular Pharmacology, 41(4), 586–592.

    Article  PubMed  CAS  Google Scholar 

  53. van den Brand, M., Laarman, G. J., Steg, P. G., De Scheerder, I., Heyndrickx, G., Beatt, K., et al. (1999). Assessment of coronary angiograms prior to and after treatment with abciximab, and the outcome of angioplasty in refractory unstable angina patients. Angiographic results from the CAPTURE trial. European Heart Journal, 20(21), 1572–1578.

    Article  PubMed  Google Scholar 

  54. De Lemos, J. A., Antman, E. M., Gibson, C. M., McCabe, C. H., Giugliano, R. P., Murphy, S. A., et al. (2000). Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation, 101(3), 239–243.

    PubMed  Google Scholar 

  55. Neumann, F. J., Blasini, R., Schmitt, C., Alt, E., Dirschinger, J., Gawaz, M., et al. (1998). Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation, 98(24), 2695–2701.

    PubMed  CAS  Google Scholar 

  56. Gibson, C. M., Murphy, S. A., Rizzo, M. J., Ryan, K. A., Marble, S. J., McCabe, C. H., et al. (1999). Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis in Myocardial Infarction (TIMI) Study Group. Circulation, 99(15), 1945–1950.

    PubMed  CAS  Google Scholar 

  57. Thiele, H., Schindler, K., Friedenberger, J., Eitel, I., Furnau, G., Grebe, E., et al. (2008). Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation, 118(1), 49–57.

    Article  PubMed  CAS  Google Scholar 

  58. Pomerantz, R. M., Kuntz, R. E., Diver, D. J., Safian, R. D., & Baim, D. S. (1991). Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following PTCA. Catheterization and Cardiovascular Diagnosis, 24(4), 283–285.

    Article  PubMed  CAS  Google Scholar 

  59. Kaplan, B. M., Benzuly, K. H., Kinn, J. W., Bowers, T. R., Tilli, F. V., Grines, C. L., et al. (1996). Treatment of no-reflow in degenerated saphenous vein graft interventions: comparison of intracoronary verapamil and nitroglycerin. Catheterization and Cardiovascular Diagnosis, 39(2), 113–118.

    Article  PubMed  CAS  Google Scholar 

  60. Kaminski, P. M., & Proctor, K. G. (1989). Attenuation of no-reflow phenomenon, neutrophil activation, and reperfusion injury in intestinal microcirculation by topical adenosine. Circulation Research, 65(2), 426–435.

    PubMed  CAS  Google Scholar 

  61. Micari, A., Belcik, T. A., Balcells, E. A., Powers, E., Wei, K., Kaul, S., et al. (2005). Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. The American Journal of Cardiology, 96(10), 1410–1415.

    Article  PubMed  CAS  Google Scholar 

  62. Movahed, M. R., & Baweja, G. (2008). Distal administration of very high doses of intracoronary adenosine for the treatment of resistant no-reflow. Experimental and Clinical Cardiology, 13(3), 141–143.

    PubMed  Google Scholar 

  63. Parikh, K. H., Chag, M. C., Shah, K. J., Shah, U. G., Baxi, H. A., Chandarana, A. H., et al. (2007). Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning. Canadian Journal of Physiology and Pharmacology, 85(3–4), 476–482.

    Article  PubMed  CAS  Google Scholar 

  64. Hillegass, W. B., Dean, N. A., Liao, L., Rhinehart, R. G., & Myers, P. R. (2001). Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: initial human clinical experience. Journal of the American College of Cardiology, 37(5), 1335–1343.

    Article  PubMed  CAS  Google Scholar 

  65. Grines, C., Patel, A., Zijlstra, F., Weaver, W. D., Granger, C., & Simes, R. J. (2003). Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. American Heart Journal, 145(1), 47–57.

    Article  PubMed  CAS  Google Scholar 

  66. Grines, C. L., Browne, K. F., Marco, J., Rothbaum, D., Stone, G. W., O'Keefe, J., et al. (1993). A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. The New England Journal of Medicine, 328(10), 673–679.

    Article  PubMed  CAS  Google Scholar 

  67. Grines, C. L., Cox, D. A., Stone, G. W., Garcia, E., Mattos, L. A., Giambartolomei, A., et al. (1999). Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. The New England Journal of Medicine, 341(26), 1949–1956.

    Article  PubMed  CAS  Google Scholar 

  68. Burzotta, F., De Vita, M., Gu, Y. L., Isshiki, T., Lefevre, T., Kaltoft, A., et al. (2009). Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. European Heart Journal, 30(18), 2193–2203.

    Article  PubMed  Google Scholar 

  69. Tamhane, U. U., Chetcuti, S., Hameed, I., Grossman, P. M., Moscucci, M., & Gurm, H. S. (2010). Safety and efficacy of thrombectomy in patients undergoing primary percutaneous coronary intervention for acute ST elevation MI: a meta-analysis of randomized controlled trials. BMC Cardiovasc Disord, 10, 10.

    Article  PubMed  Google Scholar 

  70. Burzotta, F., Trani, C., Romagnoli, E., Mazzari, M. A., Rebuzzi, A. G., De Vita, M., et al. (2005). Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. Journal of the American College of Cardiology, 46(2), 371–376.

    Article  PubMed  Google Scholar 

  71. De Luca, L., Sardella, G., Davidson, C. J., De Persio, G., Beraldi, M., Tommasone, T., et al. (2006). Impact of intracoronary aspiration thrombectomy during primary angioplasty on left ventricular remodelling in patients with anterior ST elevation myocardial infarction. Heart, 92(7), 951–957.

    Article  PubMed  Google Scholar 

  72. Ikari, Y., Sakurada, M., Kozuma, K., Kawano, S., Katsuki, T., Kimura, K., et al. (2008). Upfront thrombus aspiration in primary coronary intervention for patients with ST-segment elevation acute myocardial infarction: report of the VAMPIRE (VAcuuM asPIration thrombus REmoval) trial. JACC. Cardiovascular Interventions, 1(4), 424–431.

    Article  PubMed  Google Scholar 

  73. Kaltoft, A., Bottcher, M., Nielsen, S. S., Hansen, H. H., Terkelsen, C., Maeng, M., et al. (2006). Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation, 114(1), 40–47.

    Article  PubMed  Google Scholar 

  74. Lefevre, T., Garcia, E., Reimers, B., Lang, I., di Mario, C., Colombo, A., et al. (2005). X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. Journal of the American College of Cardiology, 46(2), 246–252.

    Article  PubMed  Google Scholar 

  75. Sardella, G., Mancone, M., Bucciarelli-Ducci, C., Agati, L., Scardala, R., Carbone, I., et al. (2009). Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. Journal of the American College of Cardiology, 53(4), 309–315.

    Article  PubMed  Google Scholar 

  76. Silva-Orrego, P., Colombo, P., Bigi, R., Gregori, D., Delgado, A., Salvade, P., et al. (2006). Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. Journal of the American College of Cardiology, 48(8), 1552–1559.

    Article  PubMed  Google Scholar 

  77. Stone, G. W., Cox, D. A., Babb, J., Nukta, D., Bilodeau, L., Cannon, L., et al. (2003). Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries. Journal of the American College of Cardiology, 42(11), 2007–2013.

    Article  PubMed  Google Scholar 

  78. Svilaas, T., Vlaar, P. J., van der Horst, I. C., Diercks, G. F., de Smet, B. J., van den Heuvel, A. F., et al. (2008). Thrombus aspiration during primary percutaneous coronary intervention. The New England Journal of Medicine, 358(6), 557–567.

    Article  PubMed  CAS  Google Scholar 

  79. Ali, A., Cox, D., Dib, N., Brodie, B., Berman, D., Gupta, N., et al. (2006). Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. Journal of the American College of Cardiology, 48(2), 244–252.

    Article  PubMed  Google Scholar 

  80. Migliorini, A., Stabile, A., Rodriguez, A. E., Gandolfo, C., Rodriguez Granillo, A. M., Valenti, R., et al. (2010). Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol, 56(16), 1298–1306.

    Article  PubMed  Google Scholar 

  81. Matar, F., Gloer, K., Barrett, C., Sires, O., Thakore, S., Warner, J., et al. (2006). Synergism of rheolytic thrombectomy and embolic distal protection using the percusurge guard wire for fresh thrombus removal: an in vitro study. Acute Cardiac Care, 8(1), 31–34.

    Article  PubMed  Google Scholar 

  82. Baim, D. S., Wahr, D., George, B., Leon, M. B., Greenberg, J., Cutlip, D. E., et al. (2002). Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation, 105(11), 1285–1290.

    PubMed  Google Scholar 

  83. Stone, G. W., Webb, J., Cox, D. A., Brodie, B. R., Qureshi, M., Kalynych, A., et al. (2005). Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. Journal of the American Medical Association, 293(9), 1063–1072.

    Article  PubMed  CAS  Google Scholar 

  84. Gick, M., Jander, N., Bestehorn, H. P., Kienzle, R. P., Ferenc, M., Werner, K., et al. (2005). Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation, 112(10), 1462–1469.

    Article  PubMed  Google Scholar 

  85. Kelbaek, H., Terkelsen, C. J., Helqvist, S., Lassen, J. F., Clemmensen, P., Klovgaard, L., et al. (2008). Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. Journal of the American College of Cardiology, 51(9), 899–905.

    Article  PubMed  Google Scholar 

  86. Matar, F. A., Smith, K., Rossi, P., Vandormael, M., Sullebarger, J. T., Taylor, M., et al. (2009). Limitations of embolic protection in saphenous vein graft intervention: insights from 202 consecutive patients. Journal of Interventional Cardiology, 22(3), 240–246.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tampa General Hospital, 509 South Armenia, Suite 200, Tampa, FL, 33609, USA

    Fadi Matar

  2. Faculté de Médecine, Université Saint Joseph, Beirut, Lebanon

    Jad Mroue

Authors
  1. Fadi Matar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jad Mroue
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fadi Matar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matar, F., Mroue, J. The Management of Thrombotic Lesions in the Cardiac Catheterization Laboratory. J. of Cardiovasc. Trans. Res. 5, 52–61 (2012). https://doi.org/10.1007/s12265-011-9327-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-011-9327-6

Keywords

Search

Navigation